| Date | Title | Description |
| 28.08.2026 | Breast Cancer Liquid Biopsy Market Trends: Precision Oncology and Minimally Invasive Diagnostics Driving Growth | The breast cancer liquid biopsy market is emerging as a promising segment of precision oncology as healthcare providers increasingly seek minimally invasive approaches for cancer detection, monitoring, and treatment planning. Liquid biopsy ... |
| 27.08.2026 | Preimplantation Genetic Diagnosis Market to Reach USD 1,135.0 Million by 2030 | The global Preimplantation Genetic Diagnosis Market is projected to grow from USD 690.2 million in 2025 to USD 1,135.0 million by 2030, registering a CAGR of 10.5% during the forecast period. Market growth is being driven by the increasing ... |
| 21.08.2026 | lab on a chip technology Market to Reach USD 21.36 Billion by 2030 | The global lab on a chip technology Market is projected to grow from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, registering a CAGR of 8.8% during the forecast period. Market growth is being driven by increasing demand for high-... |
| 10.08.2026 | The power of genetic testing: new screening methods are catching rare diseases before symptoms start | Genetic testing is helping rare disease patients get answers earlier, sometimes before symptoms appear, opening the door to treatment before irreversible damage occurs.
For families, a genetic diagnosis can provide much more than a name for... |
| 02.08.2026 | Scale AI Pivots to Enterprise Under New CEO Francis DeSouza | Scale AI names Francis DeSouza its new CEO, effective August 10. DeSouza, a veteran from Google Cloud and Illumina, will steer Scale's strategic pivot. The company moves beyond AI data labeling. Its new focus is enterprise software and gove... |
| 30.07.2026 | Scale AI taps former Google Cloud executive Francis DeSouza as CEO to fuel enterprise AI growth | Scale AI has picked a veteran enterprise software executive to lead its next chapter, signaling that the company is betting its future on selling AI products and services to businesses and governments rather than remaining known primarily a... |
| 28.07.2026 | China is building more legal tools for foreign-related disputes. What does it mean for companies, individuals? | Listen
13 min
New: You can now listen to articles.
This audio is generated by an AI tool.
BEIJING: As geopolitical tensions deepen, China is expanding the role of domestic law in responding to foreign sanctions, export controls and other fo... |
| 17.07.2026 | Juno Bio Raises $3.8M in Funding | Juno Bio, an Oakland, California-based developer of precision multi-omics and vaginal microbiome testing platforms, raised $3.8m in funding.
Backers included Ada Ventures, Artesian, Entrepreneur First, and Illumina Accelerator.
The company ... |
| 16.07.2026 | Juno Bio secures $3.8M and opens first sequencing lab dedicated to women's health | Juno Bio, a UK-founded women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s health... |
| 16.07.2026 | Juno Bio Raises $3.8 Million And Opens First CLIA-Certified Sequencing Lab Dedicated Entirely To Women’s Health | Juno Bio, a women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, announced the opening of its first sequencing lab built entirely for women’s health. The new facilit... |
| 15.07.2026 | Biochips Market to Reach $21.36 Billion by 2030 | The global biochips market is projected to grow from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, at a CAGR of 8.8% during the forecast period. Market growth is fueled by increasing demand for faster, more accurate, and cost-effe... |
| 13.07.2026 | Molecular Cytogenetics Market to Reach $1.43 Billion by 2030 | The global molecular cytogenetics market is projected to grow from USD 1.02 billion in 2025 to USD 1.43 billion by 2030, at a CAGR of 7.1% during the forecast period. Market growth is primarily driven by the increasing incidence of cancer a... |
| 07.07.2026 | Molecular Diagnostics Market to Reach $30.74 Billion by 2030 | The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investment... |
| 01.06.2026 | ClearNote Health Secures $52M to Expand Early Cancer Detection | ClearNote Health secured $52 million in Series D funding. This capital fuels accelerated growth in early cancer detection. The round elevates total funding to $185 million. New President and COO Kevin Keegan joins the leadership. ClearNote ... |
| 27.05.2026 | ClearNote Health: $52 Million Series D Raised To Accelerate Early Cancer Detection Growth | ClearNote Health announced it has secured $52 million in Series D financing and appointed clinical oncology diagnostics veteran Kevin Keegan as president and chief operating officer. The company said the funding and leadership expansion wil... |
| 14.05.2026 | US-China Summit: Corporate Giants Confront Global Tensions | President Trump heads to China for pivotal talks. A powerful U.S. executive delegation, including leaders from Tesla, Apple, and BlackRock, accompanies him. The summit agenda confronts critical issues: trade disputes, advanced AI technology... |
| 12.05.2026 | Tesla CEO Elon Musk and Nvidia CEO Jensen Huang travel to China aboard Air Force One with Trump | Getting your Trinity Audio player ready...
By MICHELLE CHAPMAN, AP Business Writer
Prominent U.S. executives from Big Tech and Wall Street to agriculture and aerospace are joining President Donald Trump on his trip to China this week.
Trump... |
| 11.05.2026 | Trump invites Elon Musk, Tim Cook, Larry Fink and other CEOs to join China trip for Xi summit | President Donald Trump invited executives including Elon Musk, Tim Cook and Larry Fink to join his trip to China this week.
Trump and Chinese President Xi Jinping are expected to discuss trade, artificial intelligence, export controls, Taiw... |
| 03.04.2026 | Assembling Over 1,000 Human Genomes Affordably: New Method Powers Medicine's Future | HANGZHOU, China, April 3, 2026 /PRNewswire/ -- A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators, published their latest findings in Nature on April... |
| 27.02.2026 | Illumina Launches TruPath Genome, Unveils NovaSeq X Roadmap, and Drives Cancer Breakthroughs with Connected Multiomics | TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow, and the new AGBT data demonstrates its accuracy in detecting rare genetic diseases
40% increase in output to 35 billion reads, up to Q70 quality sc... |
| 26.02.2026 | Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics | At AGBT, researchers reveal new findings from studies leveraging Illumina's multiomics solutions
SAN DIEGO, Feb. 26, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced new customer breakthroughs in oncology powered by Illumina's s... |
| 25.02.2026 | Illumina launches TruPath Genome, setting a new standard in genomic insight | TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflow
Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease
Broad Clinical Labs is among first to adopt product,... |
| 24.02.2026 | Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility | 40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are among the updates to be rolled out on all NovaSeq X systems, advancing precision medicine and delivering compounded val... |
| 20.01.2026 | Soulmates Ventures Backs FluoSphera Rethinking Preclinical Drug Development | With Soulmates Ventures’ support, Fluosphera is building scalable, human-relevant preclinical models to reduce drug development failure Its multiplexed platform enables early, decision-grade insights across multiple interacting human tissue... |
| 12.01.2026 | Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team | T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., ... |
| 18.12.2025 | Bringing rapid, lab-grade diagnostics to the pond side | - |
| 12.11.2025 | Hepta Unveils AI Liquid Biopsy for Chronic Disease | Hepta secures $6.7M. It pioneers AI-driven liquid biopsy for chronic diseases, starting with MASH. Its transformer AI platform analyzes cell-free DNA epigenomes. This delivers unparalleled precision in diagnosis. The non-invasive blood test... |
| 10.11.2025 | Hepta Emerges from Stealth with $6.7M to Pioneer AI-Driven Chronic Disease Liquid Biopsy | What You Should Know:
– Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures,... |
| 06.11.2025 | Hepta: $6.7 Million Seed Funding Closed To Advance Liquid Biopsy-Based AI Diagnostics For Chronic Liver Disease | Hepta, a biotechnology company developing a transformer-based artificial intelligence platform to analyze the cell-free DNA epigenome, has emerged from stealth with $6.7 million in seed funding. The round was led by Felicis Ventures and Ill... |
| 05.11.2025 | Global medical firms showcase innovations at CIIE | The Pascal precision transcatheter valve repair system is showcased at the booth of Edwards Lifesciences, a US-based structural heart innovation company, during the 8th CIIE held in Shanghai. [Photo provided to chinadaily.com.cn]
The 8th Ch... |
| 17.10.2025 | Roche sets gene-sequencing record. It’s a challenge for Illumina. | - |
| 17.10.2025 | Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot | Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx
Constellation outperformed orthogonal methods in identifying select difficult-to-map variants
SAN DIEGO, Oct. 17, 2025 /PRNewswir... |
| 16.10.2025 | Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights | At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases
Proprietary 5-base chemistry and novel DRAGEN algorith... |
| 07.10.2025 | Predicta Biosciences: $23.4 Million Series A Raised To Advance Diagnostic And Therapeutic Discovery Tools | Predicta Biosciences, a precision oncology company focused on developing advanced diagnostic and therapeutic discovery tools, has announced the close of a $23.4 million Series A funding round. The funding round was oversubscribed and led by... |
| 06.10.2025 | Halia Therapeutics Strengthens Global Genomics Leadership with Appointment of Paul Jones as Chief Strategy Officer & GM, International Markets | New CSO & GM role underscores Halia's commitment to resilience-based therapeutic development and advances collaboration with the Department of Health – Abu Dhabi
LEHI, Utah, Oct. 6, 2025 /PRNewswire/ -- Halia Therapeutics (The Genetic R... |
| 02.10.2025 | Predicta Biosciences Raises $23.4M in Series A Funding | Predicta Biosciences, a Cambridge, MA-based precision oncology company developing novel diagnostic and therapeutic discovery solutions, raised $23.4m in Series A funding.
The round was led by Engine Ventures with particiaption from Illumina... |
| 11.09.2025 | China’s Domestic Sequencers Take Bigger Market Share in First Half After Illumina Import Ban | (Yicai) Sept. 11 -- The Chinese market share of domestically made genome-sequencing products has increased in the first half of the year, as the country imposed an import ban on US gene-sequencing equipment giant Illumina early this year.
A... |
| 03.09.2025 | Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development | Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease
Following early access program, customers commend scale, high consistency, and ... |
| 03.09.2025 | Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game | CAMBRIDGE, England, Sept. 3, 2025 /PRNewswire/ -- 'OrcaCam' showcases Cambridge's history of innovation and demonstrates how a simple QR code can instantly launch a cross-platform game on any device - with no download required.
OrcaCam, a r... |
| 02.09.2025 | Scan, Play, Discover: Orca Scan Launches QR-Powered Retro Game | CAMBRIDGE, England, Sept. 2, 2025 /PRNewswire/ -- 'OrcaCam' showcases Cambridge's history of innovation and demonstrates how a simple QR code can instantly launch a cross-platform game on any device - with no download required.
OrcaCam, a r... |
| 19.08.2025 | Nilesh Shah joins Illumina as Head of Region, AMEA | SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately.
Nilesh Sha... |
| 22.07.2025 | Illumina India Wins the Top GCC Award at the 2025 GCC Workplace Awards | Bengaluru, Karnataka, India
Illumina Inc. (NASDAQ: ILMN), a global leader in sequencing technology, announced today that Illumina India has won the Top GCC Award at the 2025 GCC Workplace Awards, hosted by the Zyoin Group. The award recogni... |
| 16.07.2025 | Brown Cancer Center - First In U.S. To Offer New Comprehensive Cancer Sequencing | UofL Health - Brown Cancer Center
UofL Health – Brown Cancer Center recently became the first facility in the United States of America to offer its patients access to an FDA approved assay for solid tumor testing. The test, known as Illumin... |
| 16.07.2025 | ABPI: UK aims high on life sciences, but investment lags behind | The government’s newly unveiled Life Sciences Sector Plan lays out an ambition to position the UK as a global life sciences leader by 2030.
But the pharmaceutical industry has pushed back, warning that without major reforms to medicine fund... |
| 25.06.2025 | Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy | Combines highly complementary proteomics expertise with Illumina's industry-leading product innovation and global market reach
Positions Illumina to achieve growth in a large, expanding market
Illumina and SomaLogic have partnered in proteo... |
| 24.06.2025 | Cambridge science has global ambitions and London is our departure lounge | Cambridge is seizing a unique moment to amplify the global impact of its world-leading research by opening a new office in London’s tech hub, aiming to build stronger connections, embrace entrepreneurial risk, and better integrate academia ... |
| 23.06.2025 | Illumina buying Boulder’s SomaLogic for more than $350M | Less than two years after Boulder-based biotech firm SomaLogic Inc. merged with Standard BioTools Inc. (Nasdaq: LAB), Illumina Inc. (NASDAQ: ILMN) has inked a deal to absorb SomaLogic’s business in an acquisition worth as much as $425 milli... |
| 23.06.2025 | Federal Reserve’s Bowman says rate cut should be on table in July | Related Articles
Illumina buying Boulder’s SomaLogic for more than $350M
Boulder boasts nation’s best restaurant in Frasca
Compass files lawsuit against Zillow over private home listings policy
Why target-date funds are great IRA investment... |
| 18.06.2025 | Why Claims Data Alone Leave Gaps in Understanding the Patient Journey | Noah Nasser, CEO at datma
In today’s precision medicine landscape, pharmaceutical companies and access teams face a critical challenge: understanding not just whether therapies work, but how they are accessed, adopted, and experienced by re... |
| 17.06.2025 | Navigating the Future of Pregnancy Safety Studies and Genomic Innovations in Oncology | In the ever-evolving landscape of healthcare, two significant developments are shaping the future: pregnancy safety studies and advancements in genomic oncology. Both areas face unique challenges and opportunities, but they share a common g... |
| 17.06.2025 | Arima Genomics: $22 Million Series C Funding Closed And Tom Willis Named As CEO | Arima Genomics – a company utilizing whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights – announced the appointment of Tom Willis, PhD, as CEO and the closing of a $22 million Series C... |
| 06.06.2025 | JPMorgan’s top biotech and pharma picks for the second half | - |
| 04.06.2025 | Health-care stocks are due for a turnaround after a historically bad month, according to the charts | - |
| 02.06.2025 | EU Poised to Curb China’s Access to Medical Device Procurement | - |
| 31.05.2025 | The Future of Diagnostics and AI: A New Dawn in Rare Disease Detection and Semiconductor Solutions | In the ever-evolving landscape of technology and healthcare, two significant advancements have emerged that promise to reshape our understanding of rare diseases and the infrastructure that supports artificial intelligence (AI). Illumina's ... |
| 30.05.2025 | Illumina Unveils Promoterai, a Groundbreaking Algorithm to Accelerate Insights for Rare Disease Diagnosis | Illumina Inc..today unveiled PromoterAI, a new AI algorithm that accurately deciphers pathogenic regulatory genetic variants in the noncoding regions of the human genome. A study published today in Science illustrates how this deep learning... |
| 29.05.2025 | Pillar Biosciences Secures $34.5 Million to Propel Decision Medicine Forward | Pillar Biosciences is on the rise. The Natik, Massachusetts-based company has secured $34.5 million in funding. This infusion comes from a mix of strategic investors, including Illumina and Soleus Capital. The goal? To enhance their Decisio... |
| 29.05.2025 | Pillar Biosciences: $34.5 Million Raised For Decision Medicine Platform | Pillar Biosciences, a leader in Decision Medicine, announced they have finalized $34.5 million in funding, including a strategic investment from Illumina, structured financing from Soleus Capital, and investments from existing investors.
Ho... |
| 28.05.2025 | These biotech stocks will benefit as generative AI speeds up drug discovery, Jefferies says | - |
| 27.05.2025 | Pillar Biosciences Raises $34.5M in Funding | Pillar Biosciences, a Natik, MA-based decision medicine company, raised $34.5M in funding.
Backers included Illumina, Soleus Capital and existing investors.
The company intends to use the funds to advance its commercial activities including... |
| 28.04.2025 | Фармрынок идет на поправку | - |
| 19.04.2025 | The Future of Health: A New Era of Longevity and Precision Medicine | In the heart of Abu Dhabi, a significant shift in healthcare is taking shape. The "Declaration on Longevity and Precision Medicine" was unveiled during the Abu Dhabi Global Health Week (ADGHW). This declaration is not just a docum... |
| 19.04.2025 | Declaration on longevity and precision medicine launched at Abu Dhabi Global Health Week | Establishing actionable frameworks to advance precision medicine and longevity science
The declaration highlights the impact longevity and precision medicine can have on supporting healthy communities, and engages leaders to work towards ac... |
| 17.04.2025 | A New Dawn in Pediatric Health: Ziresovir's Breakthrough Against RSV | In the world of pediatric medicine, a storm brews. Respiratory syncytial virus (RSV) is a formidable foe, striking down infants and young children with relentless ferocity. Each year, millions of cases emerge, leading to countless hospitali... |
| 16.04.2025 | Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation Awards for transformative impact | Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug delivery, and novel pain treatments
Recipients include the Children's Hospital of Philadelphia, University of Pennsyl... |
| 15.04.2025 | Illumina and Tempus Partner to Drive the Future of Precision Medicine Through Genomic AI Innovation | Illumina a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. ... |
| 15.04.2025 | Назад, в генетическое будущее | - |
| 04.04.2025 | This Is the Overlooked Industry You Should Start Investing in Now Learn about the rapidly growing healthtech sector, including key investment areas, potential risks and future trends, to make informed... | In 2019, a ground-breaking procedure took place in Sanya, China, where a surgeon used state-of-the-art surgery tools to implant a stimulation device into the brain of a Parkinson's patient.
Why is this so remarkable, you ask? The patient wa... |
| 29.03.2025 | Here are analysts’ favorite Nasdaq 100 stocks heading into the second quarter | - |
| 22.03.2025 | America needs a jab in its corporate backside | - |
| 20.03.2025 | The aging population is a $1 trillion opportunity. These stocks are the winners, says Mizuho | - |
| 15.03.2025 | Arista Networks: The Backbone of AI Performance | In the ever-evolving landscape of technology, artificial intelligence (AI) stands as a towering giant. Companies scramble to harness its power, but one crucial element often goes unnoticed: the network. A robust network is the unsung hero b... |
| 13.03.2025 |
Cramer’s Lightning Round: Nano Nuclear Energy is a sell | Monday - Friday, 6:00 - 7:00 PM ET
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Illumina: “Illumina is a challenged company... |
| 10.03.2025 | Illumina lowers outlook due to China sales ban, to cut $100 million in costs | Illumina lowers outlook due to China sales ban, to cut $100 million in costs
By ReutersMarch 10, 20258:36 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
A sign at the front entrance to the glob... |
| 04.03.2025 | Stocks making the biggest moves premarket: Nvidia, Tesla, Target, Illumina and more | - |
| 24.02.2025 | iHope Genetic Health Hits 500+ Cases, Strengthens Global Network | Join iHope Genetic Health
Donate QR Code
iHope Genetic Health Program marks a milestone in advancing genetic care for underserved populations. DAMASCUS, MD, UNITED STATES, February 24, 2025 /EINPresswire.com/ -- iHope Genetic Health is thri... |
| 21.02.2025 | Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions | Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it secured $30 million in its Series D financing. The funding round was led by a strategic investor, along with part... |
| 20.02.2025 | JPMorgan’s top biopharma picks for 2025 | - |
| 20.02.2025 | Chinese Rivals Seize on Illumina’s Blacklisting to Woo Clients | (Bloomberg) -- Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant.
While Illumina is still assessing the consequences of being adde... |
| 08.02.2025 | Deel: New Anchor Investors And Financial Milestone Announced | Leading payroll and HR company Deel announced that new anchor investors, including General Catalyst and a sovereign investor, have purchased close to $300 million in Deel secondaries from early investors. These investments signal Deel’s mom... |
| 07.02.2025 | Illumina forecasts 2025 revenue largely below estimates | Illumina forecasts 2025 revenue largely below estimates
By ReutersFebruary 6, 20259:42 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
An Illumina office building is shown in San Diego, Californ... |
| 07.02.2025 | Illumina Is in Talks With Authorities, US Firm Says After Being Added to China's Unreliable Entity List | (Yicai) Feb. 7 -- Illumina is in talks with relevant authorities to find a valid solution, the US gene sequencing giant said after being added to China's unreliable entity list.
"The company is actively communicating with relevant auth... |
| 05.02.2025 | Sequins™: A New Era in Genomic Control | In the bustling world of genomics, Sequins™ has emerged as a beacon of innovation. This San Francisco-based start-up is not just another player in the next-generation sequencing (NGS) ecosystem; it’s a game changer. With the launch of its f... |
| 05.02.2025 | PepsiCo's Resilience Amid Global Challenges: A Deep Dive into Recent Performance | PepsiCo's recent performance in India paints a picture of resilience and growth, even as global markets face uncertainty. The company reported double-digit organic revenue growth in 2024, showcasing its ability to thrive in a competitive la... |
| 05.02.2025 | Trade Wars and Tech Giants: The Tug-of-War Between the U.S. and China | The economic landscape is a battlefield. Tariffs are the weapons. The U.S. and China are locked in a fierce struggle, each trying to outmaneuver the other. The latest skirmish? China’s new tariffs on U.S. goods and an investigation into Goo... |
| 05.02.2025 | Wall Street rises on US-China trade optimism, energy boost | Wall Street rises on US-China trade optimism, energy boost
By Abigail Summerville and Sukriti GuptaFebruary 4, 20259:43 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
PepsiCo, ... |
| 05.02.2025 | Trump in no hurry to talk to Xi amid new tariff war | Trump in no hurry to talk to Xi amid new tariff war
By Jeff Mason, Trevor Hunnicutt and Kevin KrolickiFebruary 4, 20259:12 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
'That'... |
| 05.02.2025 | Sequins™ Announces Availability of First Products - Bolsters Team for Commercialization | SAN FRANCISCO, Feb. 5, 2025 /PRNewswire/ -- Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and ... |
| 04.02.2025 | China announces measures against Google, other US firms, as trade tensions escalate | BEIJING: China announced a wide range of measures on Tuesday (Feb 4) targeting US businesses including Google, farm equipment makers and the owner of fashion brand Calvin Klein, minutes after new US tariffs on Chinese goods took effect.
Adv... |
| 04.02.2025 | The 10 Biggest Rounds Of January: Infinite Reality Tops Busy Month | 8 Shares Email Facebook Twitter LinkedIn
This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out November’s biggest rounds here.
The year started strong for huge rounds, as the first month saw a trio... |
| 04.02.2025 | National Politics | China counters with tariffs on US products. It will also investigate Google | “It’s aiming for finding measures that maximize the impact and also minimize the risk that the Chinese economy may face,” said Gary Ng, a senior economist at Natixis Corporate and Investment Banking in Hong Kong. “At the same time … China i... |
| 04.02.2025 | China to impose 15% tariff on imports of coal, LNG from US in response to Trump's trade moves | BEIJING: China's finance ministry on Tuesday (Feb 4) announced a package of tariffs on a range of US products in an immediate response to a 10 per cent tariff on Chinese imports announced by US President Donald Trump.
Advertisement
To end t... |
| 17.01.2025 | Truveta's Bold Leap into Genomic Data: A New Era for Healthcare | In the realm of healthcare, data is the new gold. Truveta, a data company born from the collaboration of leading health systems, is striking while the iron is hot. With a recent $320 million investment, Truveta is poised to revolutionize ho... |
| 17.01.2025 | The Week’s Biggest Funding Rounds: Biotech And Space Tech Bring In The Money | 9 Shares Email Facebook Twitter LinkedIn
Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.
This is a w... |
| 16.01.2025 | Truveta: EHR Data Company Raises $320 Million At Over $1 Billion Valuation | Leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announced the Truveta Genome Project, which is an innovative collaboration to generate genetic d... |
| 16.01.2025 | Clear Labs: $30 Million (Series D) Secured For Advancing Development Of Sequencing Solutions | Clear Labs, a provider of fully automated and next-generation sequencing (NGS) platforms for turnkey diagnostics, announced it has raised $30 million in its Series D financing. This funding round was led by a strategic investor, along with ... |
| 15.01.2025 | The Race for AI: Innovation and Impending Doom | In the world of artificial intelligence, innovation races ahead like a speeding train. Researchers from AIRI, along with their international partners, have made headlines by reaching the finals of the prestigious Concordia Challenge. This c... |
| 14.01.2025 | Нейросети, робототехника и апокалипсис | Как повлияет развитие нейросетей и робототехники на рынок труда? Появится ли в ближайшие годы настоящий сильный ИИ? Если сильный ИИ появится - захочет ли он уничтожить человечество? Не используют ли власти большинства стран нейросети, ИИ и ... |
| 13.01.2025 | Clear Labs Secures $30 Million in Series D Financing to Accelerate Development and Adoption of Cutting-Edge Sequencing Solutions | Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for the clinical and applied markets.
Leader in Next-Generation Sequencing Advances Innovation in Healthcare with Capital and Appointment of ... |
| 11.01.2025 | The Hidden Dangers of DNA Sequencers and Data Privacy | In the age of technology, DNA sequencers are the unsung heroes of genetic research. They unlock the secrets of our genes, revealing connections and histories that shape who we are. But beneath this surface lies a troubling vulnerability. Re... |
